While Ozempic (Semaglutide) and Mounjaro (Tirzepatide) are highly effective for weight loss, they can interact with other medications. These interactions might impact medication effectiveness or increase side effects.

GLP-1 receptor agonists interact with other medications through two primary mechanisms:

  • Slowing gastric emptying

  • Modifying blood sugar metabolism

This can influence how your body absorbs or responds to other drugs. Here’s what you need to know.

Antidiabetic Medications

GLP-1 agonists support healthy blood sugar levels and enhance your body’s natural insulin production. However, combining them with other diabetes medications requires caution. Since both lower blood sugar, using them together can result in dangerously low blood sugar levels if not closely monitored.

Potential Risks:

  • Insulin and Sulfonylureas can amplify glucose-lowering effects

  • Significantly increased hypoglycemia risk

  • Potential for dangerously low blood sugar levels

Medications Requiring Careful Monitoring:

  • Insulin

  • Metformin

  • Januvia (sitagliptin)

  • SGLT2 blockers (Farxiga, Invokana)

  • Sulfonylureas (Amaryl, DiaBeta, Glucotrol)

Recommended Action: Consistent blood sugar level monitoring with healthcare professional guidance.

Blood Pressure Medications

Some blood pressure medications can occasionally lead to low blood sugar as a side effect. While GLP-1 receptor agonists may interact with these medications, the interactions are typically mild and rarely require dose adjustments.

Research Findings:

  • ACE inhibitors showed minimal interaction risks

  • Potential blood sugar level modifications

  • Indirect insulin sensitivity impacts

Key Medications to Watch:

  • ACE inhibitors (Zestril, Altace)

  • Angiotensin II receptor blockers (Cozaar, Diovan)

Hormonal Contraceptives

Current Understanding:

  • Potential delayed absorption

  • Recommendations to take contraceptives 1 hour before GLP-1 administration

  • Researchers suggest minimal significant impact

Antibiotic Medications

Certain antibiotics can cause low blood sugar.

Antibiotics Requiring Monitoring:

  • Fluoroquinolones (Levaquin, Ciproxin)

  • Macrolides

  • Penicillins

  • Tetracyclines

Potential Effects:

  • Possible blood sugar control disruption

  • Increased metabolic variability

Antidepressant Medications

Certain medications prescribed for anxiety and depression can potentially lead to low blood sugar as a side effect. Research has shown that some antidepressants may interfere with blood glucose regulation, potentially increasing the risk of severe hypoglycemic episodes.

Medications of Metabolic Significance:

  • SSRIs (Prozac, Zoloft)

  • MAOIs (Nardil)

  • Tricyclic antidepressants (Pamelor, Silenor)

Potential Metabolic Impacts:

  • Blood sugar metabolism modifications

  • Increased hypoglycemia risk

Other medications that GLP-1s may potentially affect include:

  • Acetaminophen (Tylenol): Absorption may be slightly delayed but usually isn’t clinically significant. Taking acetaminophen 1 hour before your GLP-1 dose ensures optimal effectiveness.

  • Lanoxin (digoxin), a medication taken to treat irregular heart rate and heart disease

  • Dilantin (phenytoin), a medication to treat certain types of seizures

  • Statin medications used to treat high cholesterol and lipid levels, like Lipitor (atorvastatin) and Zocor (simvastatin)

  • Prograf (tacrolimus), a medication used to prevent organ transplant rejection

  • Coumadin (warfarin), a blood thinning medication used to treat or prevent blood clots and other heart and blood vessel conditions

Ongoing studies continue to refine our understanding of GLP-1 medication interactions. The field of metabolic pharmacology is rapidly evolving, providing increasingly nuanced insights into drug interactions.

Disclaimer: This information is based on current scientific research. Individual experiences may vary. Always consult healthcare professionals for personalized medical advice.

Subscribe for free

Each week I break down one GLP-1 question with science, trials and real answers.

Stay informed, stay well
Lucas Veritas 

I’m a true GLP-1 believer.

Tirzepatide (Mounjaro) user and patient advocate.

I lost 100+ lbs, found my energy and gained a new mission: helping others succeed with healthy weight loss on GLP-1s

Disclaimer: This article reflects my personal experience and independent research. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before making decisions about your health or treatment plan.

References:

  1. Calvarysky B, Keidar A, Leibovici L, et al. Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Drugs: A Systematic Review. J Clin Endocrinol Metab. 2024;109(2):e20-e34. https://pubmed.ncbi.nlm.nih.gov/38273155/

  2. Kolterman OG, Kim DD, Shen L, et al. Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2005;62(2):173-181. https://pubmed.ncbi.nlm.nih.gov/15700891/

  3. Buse JB, Rosenstock J, Sesti G, et al. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet. 2009;374(9683):39-47. https://pubmed.ncbi.nlm.nih.gov/19515413/

  4. Kapitza C, Forst T, Coester HV, et al. Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin. Diabetes Obes Metab. 2013;15(7):642-649. https://pubmed.ncbi.nlm.nih.gov/23368510/

  5. Elashoff M, Matveyenko AV, Gier B, et al. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology. 2011;141(1):150-156. https://pubmed.ncbi.nlm.nih.gov/21334333/

  6. Gier B, Butler PC, Lai CK, et al. Glucagon like peptide-1 receptor expression in the human thyroid gland. J Clin Endocrinol Metab. 2012;97(1):121-131. https://pubmed.ncbi.nlm.nih.gov/22031513/

  7. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010;44(5):904-909. https://pubmed.ncbi.nlm.nih.gov/20371755/

  8. Janzen KM, Steuber TD, Nisly SA. GLP-1 Agonists in Type 1 Diabetes Mellitus. Ann Pharmacother. 2016;50(8):656-665. https://pubmed.ncbi.nlm.nih.gov/27307416/

  9. American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S140-S157. https://diabetesjournals.org/care/article/46/Supplement_1/S140/148040/9-Pharmacologic-Approaches-to-Glycemic-Treatment

  10. Hinnen D. Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes. Diabetes Spectr. 2017;30(3):202-210. https://pubmed.ncbi.nlm.nih.gov/28848314/

  11. Prasad-Reddy L, Isaacs D. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs Context. 2015;4:212283. https://pubmed.ncbi.nlm.nih.gov/26213556/

  12. Zhang Y, Kahng MW, Elkind JA, et al. Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats. Neuropsychopharmacology. 2020;45(3):451-461. https://pubmed.ncbi.nlm.nih.gov/31601935/

  13. Tuesta LM, Chen Z, Duncan A, et al. GLP-1 acts on habenular avoidance circuits to control nicotine intake. Nat Neurosci. 2017;20(5):708-716. https://pubmed.ncbi.nlm.nih.gov/28368384/

Reply

Avatar

or to participate

Avatar

Jen Johnson1 year ago

Prednisone interactions I've had mild nausea, diarrhea, and a 9-week plateau after I lost 6 pounds in my first 2 weeks on tirzepatide. I wondered if my other meds might be the cause, so I listed them on a forum. Two other GLP-1 users said they'd had those side effects and no weight loss when on prednisone. A week after stopping the pred, their symptoms stopped and weight loss resumed.

I am thrilled to hope that I'll do better when I get off prednisone. I've been on it for 10 years for severe nerve pain due to skeletal deformity from scoliosis. It has kept me out of a wheelchair (I use a walker) but caused other serious problems. It's been super hard to wean off as intolerable pain and stiffness took over.

I wanted to try a GLP-1 because I read it might reduce arthritis pain. It has--by about 70%! Now with tirzepatide I hope I'll be able to wean off prednisone in the next 3-4 months, so I'm staying on a 5mg dose. Maybe I'll be able to decrease my pain meds, too. Weight loss? A bonus.

Avatar

Lucas VeritasAuthor1 year ago

Thanks for sharing!